FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311923473> ?p ?o ?g. }

• W4311923473 abstract "Abstract Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of numerous fluid-filled cysts that lead to progressive loss of functional nephrons. Currently, there is an unmet need for diagnostic and prognostic indicators of early stages of the disease. Metabolites were extracted from the urine of early-stage ADPKD patients (n=48) and age- and sex-matched normal controls (n=47) and analyzed by liquid chromatography-mass spectrometry. Orthogonal partial least squares-discriminant analysis was employed to generate a global metabolomic profile of early ADPKD for the identification of metabolic pathway alterations and discriminatory metabolites as candidates of diagnostic and prognostic biomarkers. The global metabolomic profile exhibited alterations in steroid hormone biosynthesis and metabolism, fatty acid metabolism, pyruvate metabolism, amino acid metabolism, and the urea cycle. A panel of 46 metabolite features were identified as candidate diagnostic biomarkers. Notable putative identities of candidate diagnostic biomarkers for early detection include creatinine, cAMP, dCMP, various androgens (testosterone, 5alpha-androstane-3,17,dione, trans-dehydroandrosterone), betaine aldehyde, phosphoric acid, choline, 18-hydroxycorticosterone, and cortisol. Metabolic pathways associated with variable rates of disease progression included steroid hormone biosynthesis and metabolism, vitamin D3 metabolism, fatty acid metabolism, the pentose phosphate pathway, tricarboxylic acid cycle, amino acid metabolism, sialic acid metabolism, and chondroitin sulfate and heparin sulfate degradation. A panel of 41 metabolite features were identified as candidate prognostic biomarkers. Notable putative identities of candidate prognostic biomarkers include ethanolamine, C20:4 anandamide phosphate, progesterone, various androgens (5alpha-dihydrotestosterone, androsterone, etiocholanolone, epiandrosterone), betaine aldehyde, inflammatory lipids (eicosapentaenoic acid, linoleic acid, stearolic acid), and choline. Our exploratory data support metabolic reprogramming in early ADPKD and demonstrate the ability of liquid chromatography-mass spectrometry-based global metabolomic profiling to detect metabolic pathway alterations as new therapeutic targets and biomarkers for early diagnosis and tracking disease progression of ADPKD." @default.
• W4311923473 created "2023-01-02" @default.
• W4311923473 creator A5000511408 @default.
• W4311923473 creator A5007219151 @default.
• W4311923473 creator A5008307403 @default.
• W4311923473 creator A5014577334 @default.
• W4311923473 creator A5021030176 @default.
• W4311923473 creator A5044485513 @default.
• W4311923473 creator A5048311675 @default.
• W4311923473 creator A5048672105 @default.
• W4311923473 creator A5056842256 @default.
• W4311923473 creator A5064588855 @default.
• W4311923473 creator A5073339094 @default.
• W4311923473 date "2022-12-08" @default.
• W4311923473 modified "2023-10-15" @default.
• W4311923473 title "Metabolomic Profiling to Identify Early Urinary Biomarkers and Metabolic Pathway Alterations in Autosomal Dominant Polycystic Kidney Disease" @default.
• W4311923473 cites W1964043583 @default.
• W4311923473 cites W1978121399 @default.
• W4311923473 cites W1986126285 @default.
• W4311923473 cites W1998609229 @default.
• W4311923473 cites W2005712980 @default.
• W4311923473 cites W2009712608 @default.
• W4311923473 cites W2036077644 @default.
• W4311923473 cites W2043524463 @default.
• W4311923473 cites W2069735028 @default.
• W4311923473 cites W2074832868 @default.
• W4311923473 cites W2083637865 @default.
• W4311923473 cites W2084375915 @default.
• W4311923473 cites W2097259163 @default.
• W4311923473 cites W2101067234 @default.
• W4311923473 cites W2113537053 @default.
• W4311923473 cites W2119449193 @default.
• W4311923473 cites W2130211846 @default.
• W4311923473 cites W2133122323 @default.
• W4311923473 cites W2135100794 @default.
• W4311923473 cites W2152744391 @default.
• W4311923473 cites W2161078955 @default.
• W4311923473 cites W2168609240 @default.
• W4311923473 cites W2170092490 @default.
• W4311923473 cites W2411854472 @default.
• W4311923473 cites W2476033012 @default.
• W4311923473 cites W2497366072 @default.
• W4311923473 cites W2573167551 @default.
• W4311923473 cites W2769148359 @default.
• W4311923473 cites W2776391000 @default.
• W4311923473 cites W2785987159 @default.
• W4311923473 cites W2791644192 @default.
• W4311923473 cites W2793515649 @default.
• W4311923473 cites W2897808754 @default.
• W4311923473 cites W2900484912 @default.
• W4311923473 cites W2916013068 @default.
• W4311923473 cites W2941329961 @default.
• W4311923473 cites W2965888264 @default.
• W4311923473 cites W2969442529 @default.
• W4311923473 cites W2974598582 @default.
• W4311923473 cites W2985339033 @default.
• W4311923473 cites W2994090564 @default.
• W4311923473 cites W3012348399 @default.
• W4311923473 cites W3016932145 @default.
• W4311923473 cites W3022658502 @default.
• W4311923473 cites W3026160952 @default.
• W4311923473 cites W3108108082 @default.
• W4311923473 cites W3135017796 @default.
• W4311923473 cites W4221001839 @default.
• W4311923473 cites W4283017342 @default.
• W4311923473 cites W4283827788 @default.
• W4311923473 cites W2937257129 @default.
• W4311923473 doi "https://doi.org/10.1101/2022.12.08.519365" @default.
• W4311923473 hasPublicationYear "2022" @default.
• W4311923473 type Work @default.
• W4311923473 citedByCount "1" @default.
• W4311923473 countsByYear W43119234732023 @default.
• W4311923473 crossrefType "posted-content" @default.
• W4311923473 hasAuthorship W4311923473A5000511408 @default.
• W4311923473 hasAuthorship W4311923473A5007219151 @default.
• W4311923473 hasAuthorship W4311923473A5008307403 @default.
• W4311923473 hasAuthorship W4311923473A5014577334 @default.
• W4311923473 hasAuthorship W4311923473A5021030176 @default.
• W4311923473 hasAuthorship W4311923473A5044485513 @default.
• W4311923473 hasAuthorship W4311923473A5048311675 @default.
• W4311923473 hasAuthorship W4311923473A5048672105 @default.
• W4311923473 hasAuthorship W4311923473A5056842256 @default.
• W4311923473 hasAuthorship W4311923473A5064588855 @default.
• W4311923473 hasAuthorship W4311923473A5073339094 @default.
• W4311923473 hasBestOaLocation W43119234731 @default.
• W4311923473 hasConcept C126322002 @default.
• W4311923473 hasConcept C134018914 @default.
• W4311923473 hasConcept C21565614 @default.
• W4311923473 hasConcept C2776991927 @default.
• W4311923473 hasConcept C4733338 @default.
• W4311923473 hasConcept C55493867 @default.
• W4311923473 hasConcept C60644358 @default.
• W4311923473 hasConcept C62231903 @default.
• W4311923473 hasConcept C71924100 @default.
• W4311923473 hasConcept C86803240 @default.
• W4311923473 hasConceptScore W4311923473C126322002 @default.
• W4311923473 hasConceptScore W4311923473C134018914 @default.
• W4311923473 hasConceptScore W4311923473C21565614 @default.
• W4311923473 hasConceptScore W4311923473C2776991927 @default.
• W4311923473 hasConceptScore W4311923473C4733338 @default.

• next